Management of Antibiotic-Resistant Helicobacter pylori Infection: Perspectives from Vietnam

키워드

참고문헌 (102)

1. Marshall BJ, "Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration", Lancet, 1, pp.1311~1315 (1984)
2. Blaser MJ, "Helicobacter pylori persistence : biology and disease", J Clin Invest, 113, pp.321~333 (2004)
3. Vakil N, "Eradication therapy for Helicobacter pylori", Gastroenterology, 133, pp.985~1001 (2007)
4. Fukase K, "Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer : an open-label, randomised controlled trial", Lancet, 372, pp.392~397 (2008)
5. Dinis-Ribeiro M, "Management of precancerous conditions and lesions in the stomach(MAPS) : guideline from the European Society of Gastrointestinal Endoscopy(ESGE), European Helicobacter Study Group(EHSG), European Society of Pathology(ESP), and the Sociedade Portuguesa de Endoscopia Digestiva(SPED)", Endoscopy, 44, pp.74~94 (2012)
6. Correa P, "Gastric cancer : overview", Gastroenterol Clin North Am, 42, pp.211~217 (2013)
7. Cao L, "Effect of helicobacter pylori infection on the composition of gastric microbiota in the development of gastric cancer", Gastrointest Tumors, 2, pp.14~25 (2015)
8. Malfertheiner P, "Management of Helicobacter pylori infection : the Maastricht IV", Florence Consensus Report, 2012, pp.61, 646~664
9. Banić M, "Extragastric manifestations of Helicobacter pylori infection", Helicobacter, 17(Suppl 1), pp.49~55 (2012)
10. Wroblewski LE, "Helicobacter pylori and gastric cancer : factors that modulate disease risk", Clin Microbiol Rev, 23, pp.713~739 (2010)
11. Hoang TT, "Seroprevalence of Helicobacter pylori infection in urban and rural Vietnam", Clin Diagn Lab Immunol, 12, pp.81~85 (2005)
12. Nguyen BV, "Prevalence of and factors associated with Helicobacter pylori infection in children in the north of Vietnam", Am J Trop Med Hyg, 74, pp.536~539 (2006)
13. Nguyen VB, "Intra-familial transmission of Helicobacter pylori infection in children of households with multiple generations in Vietnam", Eur J Epidemiol, 21, pp.459~463 (2006)
14. Nguyen TL, "Helicobacter pylori infection and gastroduodenal diseases in Vietnam : a cross-sectional, hospital-based study", BMC Gastroenterol, 10, pp.114~ (2010)
15. Nguyen LT, "Evaluation of rapid urine test for the detection of Helicobacter pylori infection in the Vietnamese population", Dig Dis Sci, 55, pp.89~93 (2010)
16. Dung HD, "The incidence of antibiotic resistance of Helicobacter pylori", Vietnamese J Gastroenterol, 6, pp.830~836 (2015)
17. Shiota S, "Management of Helicobacter pylori", F1000 Med Rep, 2, pp.20~ (2010)
18. Hosking SW, "Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment : randomised controlled trial", Lancet, 343, pp.508~510 (1994)
19. Shiota S, "Population-based strategies for Helicobacter pylori-associated disease management : a Japanese perspective", Expert Rev Gastroenterol Hepatol, 4, pp.149~156 (2010)
20. Malfertheiner P, "Current concepts in the management of Helicobacter pylori infection : the Maastricht III Consensus Report", Gut, 56, pp.772~781 (2007)
21. Takenaka R, "Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type", Aliment Pharmacol Ther, 25, pp.805~812 (2007)
22. Sugiyama T, "Pylori Forum Gastritis Study Group. Sensitivity of biopsy site in evaluating regression of gastric atrophy after Helicobacter pylori eradication treatment", Aliment Pharmacol Ther, 16(Suppl 2), pp.187~190 (2002)
23. McColl KE, "Helicobacter pylori infection", N Engl J Med, 362, pp.1597~1604 (2010)
24. Jenks PJ, "Causes of failure of eradication of Helicobacter pylori", BMJ, 325, pp.3~4 (2002)
25. Suzuki T, "Influence of smoking and CYP2C19 genotypes on H. pylori eradication success", Epidemiol Infect, 135, pp.171~176 (2007)
26. Mégraud F, "H pylori antibiotic resistance : prevalence, importance, and advances in testing", Gut, 53, pp.1374~1384 (2004)
27. Debets-Ossenkopp YJ, "Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands", J Antimicrob Chemother, 43, pp.511~515 (1999)
28. van der Wouden EJ, "Rapid increase in the prevalence of metronidazole-resi stant Helicobacter pylori in the Netherlands", Emerg Infect Dis, 3, pp.385~389 (1997)
29. Mégraud F, "Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori", Gastroenterology, 115, pp.1278~1282 (1998)
30. Broutet N, "Risk factors for failure of Helicobacter pylori therapy : results of an individual data analysis of 2751 patients", Aliment Pharmacol Ther, 17, pp.99~109 (2003)
31. Wheeldon TU, "The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication", Aliment Pharmacol Ther, 19, pp.1315~1321 (2004)
32. Chey WD, "American College of Gastroenterology guideline on the management of Helicobacter pylori infection", Am J Gastroenterol, 102, pp.1808~1825 (2007)
33. Binh TT, "The incidence of primary antibiotic resistance of Helicobacter pylori in Vietnam", J Clin Gastroenterol, 47, pp.233~238 (2013)
34. Phan TN, "High rate of levofloxacin resistance in a background of clarithromycin-and metronidazole-resistant Helicobacter pylori in Vietnam", Int J Antimicrob Agents, 45, pp.244~248 (2015)
35. Quek C, "Antimicrobial susceptibility and clarithromycin resistance patterns of Helicobacter pylori clinical isolates in Vietnam", F1000Res, 5, pp.671~ (2016)
36. Fock KM, "Epidemiology of Helicobacter pylori infection and gastric cancer in Asia", J Gastroenterol Hepatol, 25, pp.479~486 (2010)
37. Graham DY, "Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries", Dig Dis Sci, 36, pp.1084~1088 (1991)
38. Graham DY, "Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status", Gastroenterology, 100, pp.1495~1501 (1991)
39. Asaka M, "Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population", Gastroenterology, 102, pp.760~766 (1992)
40. Quach DT, "Value of a new stick-type rapid urine test for the diagnosis of Helicobacter pylori infection in the Vietnamese population", World J Gastroenterol, 20, pp.5087~5091 (2014)
41. Binh TT, "Molecular epidemiology of helicobacter pylori infection in a minor ethnic group of Vietnam : a multiethnic, population-based study", Int J Mol Sci, 19, pp.E708~ (2018)
42. Nguyen VB, "Epidemiology of Helicobacter pylori infection in Kinh and Khmer children in Mekong Delta, Vietnam", Ann Clin Lab Res, (S1), pp.1~9 (2015)
43. Nguyen TV, "Epidemiology of Helicobacter pylori infection in Tay children in Vietnam", Ann Clin Lab Res, 4, pp.125~ (2016)
44. Nguyen TV, "Prevalence and risk factors of Helicobacter pylori infection in Muong children in Vietnam", Ann Clin Lab Res, 5, pp.159~ (2017)
45. Lim SH, "Prevalence and risk factors of Helicobacter pylori infection in Korea : nationwide multicenter study over 13 years", BMC Gastroenterol, 13, pp.104~ (2013)
46. Long T, "The relationship between Helicobacter pylori infection and gastric cancer in Vietnamese patients : a cases control study", Vietnamese J Gastroenterol, 1, pp.10~19 (2006)
47. Thang ND, "Prevalence of Helicobacter pylori infection in patients with duodenal endoscopy at an Agricultural Hospital", Vietnamese J Gastroenterol, 2, pp.339~343 (2007)
48. Thinh NV, "Studies on Helicobacter pylori infection and mucosal lesions in patients with chronic gastritis", Ph.D, pp.2010
49. Dung HD, "Study on the relationship between cagA, vacA of Helicobacter pylori, gastrin concentration, pepsinogen and histopatholog0y in patients with chronic gastritis", Ph.D, pp.2012
50. Long T, "Gastro-duodenal disease and Helicobacter pylori bacteria" (2003), Medical Publishing House
51. Huong PT, "Study on the status of Helicobacter pylori infection and treatment response in patients with gastro-duodenal ulcer at Hue central hospital in 1998-1999", master’s, pp.1999
52. Hop TV, "Incidence of Helicobacter pylori infection in gastric cancer patients in Hanoi city and rural neighborily areas", Vietnamese J Gastroenterol, 3, pp.579~585 (2008)
53. Binh TT, "Advanced non-cardia gastric cancer and Helicobacter pylori infection in Vietnam", Gut Pathog, 9, pp.46~ (2017)
54. Lam SK, "Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection", J Gastroenterol Hepatol, 13, pp.1~12 (1998)
55. Trung TT, "Effectiveness of EAC and EAL first-line regimens for H. pylori eradication", J Med Hochiminh City, 13, pp.5~10 (2009)
56. Duat NQ, "Initially studied the fluctuation of anti-H. pylori antibodies before and after treatment with Pantoprazole + Amoxicillin + Clarithromycin", J Pract Med, 2, pp.6~12 (2007)
57. Thang ND, "Results of treatment in Helicobacter pylori gastric ulcer with Esomeprazole-Amoxicillin-Clarithromycin(EAC)regimen lasted 1 and 2 weeks", Clin Med Bachmai Hosp, 53, pp.39~43 (2010)
58. Mao HV, "Omeprazole or ranitidine bismuth citrate triple therapy to treat Helicobacter pylori infection : a randomized, controlled trial in Vietnamese patients with duodenal ulcer", Aliment Pharmacol Ther, 14, pp.97~101 (2000)
59. Hai TT, "Results of treatment of duodenal ulcer with H. pylori infection by Nexium + Amoxicillin + Clarithromycin, follow up after 6 months", master’s, pp.2002
60. Vinh NT, "The effectiveness of twice-daily first line therapy (OAC, OAM, OMC) and the second line therapies (OAC, OBMT) for patients with Helicobacter pylori positive gastro-duodenal ulcer", 4th Congress on Gastroenterology of Southeast Asian Nations. Vietnamese J Gastroenterol, 2, pp.328~332 (2003)
61. Tiep TH, "A study on assessing results of triple therapy using rabeprazole combined with amoxicillin and clarithromycin in peptic ulcer patients infected with Helicobacter pylori", Vietnamese J Gastroenterol, 3, pp.10~19 (2008)
62. Study on the antimicrobial resistance of Helicobacter pylori and the efficacy of Esomeprazole-Amoxicillin-Clarithromycin in the treatment of patients with duodenal ulcer, "Vinh NT", Scientific Research, Ministry of Health, ~ (2014)
63. Huong PT, "Study on the efficacy of combination therapy with Esomeprazole + Clarithromycine + Amoxicillin in the treatment of gastric and duodenal ulcer with Helicobacter pylori infection", Vietnamese J Gastroenterol, 5, pp.279~283 (2007)
64. Nho LV, "Effective study regimen Amoxicillin + Clarithromycin Esomeprazole + in patients with duodenal ulcer with H. pylori-positive", J Vietnamese Med, (Suppl), pp.147~153 (2011)
65. Ngoi DH, "Comparison of the regimen: Omeprazole + Amoxicillin + Levofloxacin versus Omeprazole + Amoxicillin + Clarithomycin for Helicobacter pylori eradication in patients with peptic ulcer disease", master’s, pp.2009
66. Hoang BH, "Efficacy of sequential regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease", J Med Hochiminh City, 15, pp.303~307 (2011)
67. The Vietnam Association of Gastroenterology, "Consensus on the diagnosis and treatment of Helicobacter pylori infection in Vietnam", Vietnamese J Gastroenterol, 7, pp.1929~1940 (2012)
68. Malfertheiner P, "Management of Helicobacter pylori infection-the Maastricht V", Florence Consensus Report, 2017, pp.66, 6~30
69. Fallone CA, "The Toronto consensus for the treatment of Helicobacter pylori Infection in adults", Gastroenterology, 151, pp.51~69 (2016)
70. Trung TT, "The effectiveness of EAL and EBMT regimens as the second-line therapies in Helicobacter pylori eradication", Vietnamese J Gastroenterol, 3, pp.730~735 (2008)
71. Vinh NT, "Evaluation of the effectiveness of the second line therapies EAC and EBMT for Helicobacter pylori eradication", J Pract Med, 4, pp.23~26 (2011)
72. Hue DN, "Chronic Helicobacter pylori gastritis : the eradication efficacy of the Bismuth containing quadruple regimen(EMBT)", Vietnamese J Gastroenterol, 9, pp.2862~2871 (2016)
73. Di BQ, "A study to assess efficacy of triple therapy with levofloxacin-based regime in eradication of Helicobacter pylori", J Med Pharm, 4, pp.35~41 (2011)
74. Thang HT, "Evaluating the efficacy of Rabeprazole-Levofloxacin-Tinidazole on chronic gastritis patients with positive Helicobacter pylori", Vietnamese J Gastroenterol, 9, pp.2629~2636 (2001)
75. Hoan PQ, "Study on prevalence and some biological characteristics of Helicobacter pylori in patients with duodenal ulcer before and after treatment", Ph.D, pp.2001
76. Vinh NT, "Study on the therapeutic effects of three regimens: OAM, OAC, OMC in H. pylori-positive duodenal ulcer and the effect of drug resistance on these regimens", Ph.D, pp.2003
77. Nhan LDM, "Antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease", J Med Hochiminh City, 10, pp.73~75 (2006)
78. Thinh NV, "Antibiotic resistance of Helicobacter pylori in patients with duodenal ulcer in the first 6 months of 2009", J Pract Med, 660, pp.14~18 (2009)
79. Nguyet NT, "Investigation of resistance to Helicobacter pylori isolates from patients with chronic gastritis, peptic ulcer and gastric cancer", J Pract Med, 712, pp.20~22 (2010)
80. Toan ND, "The situation of Helicobacter pylori resistance to antimicrobial susceptibility in patients with gastritis and duodenal ulcer", Vietnamese J Gastroenterol, 7, pp.1783~1789 (2012)
81. Minh DC, "Evaluate antibiotic resistance of Helicobacter pylori cultured from gastro-duodenal ulcer patients failed with eradication", Vietnamese J Gastroenterol, 9, pp.2358~2366 (2014)
82. Hue DN, "Studies on the resistance of clarithromycin and levofloxacin of Helicobacter pylori by E test and the efficacy of EBMT in chronic gastritis", Ph.D, pp.2018
83. Megraud F, "Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption", Gut, 62, pp.34~42 (2013)
84. Kuo YT, "Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region : a systematic review and meta-analysis", Lancet Gastroenterol Hepatol, 2, pp.707~715 (2017)
85. Lee JW, "Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012", Helicobacter, 18, pp.206~214 (2013)
86. O’connor A, "Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland", Eur J Gastroenterol Hepatol, 22, pp.1123~1127 (2010)
87. De Francesco V, "Worldwide H. pylori antibiotic resistance: a systematic review", J Gastrointestin Liver Dis, 19, pp.409~414 (2010)
88. Ghotaslou R, "Prevalence of antibiotic resistance in Helicobacter pylori : a recent literature review", World J Methodol, 5, pp.164~174 (2015)
89. Karczewska E, "Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland", Pharmacol Rep, 63, pp.799~807 (2011)
90. Chang WL, "Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan", J Gastroenterol Hepatol, 24, pp.1230~1235 (2009)
91. Selgrad M, "Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure of Helicobacter pylori infection", World J Gastroenterol, 20, pp.16245~16251 (2014)
92. Cuadrado-Lavín A, "Levofloxacin versus clarithromycin in a 10 day triple therapy regimen for first-line Helicobacter pylori eradication : a single-blind randomized clinical trial", J Antimicrob Chemother, 67, pp.2254~2259 (2012)
93. Hung IF, "Clarithromycin-amoxycillin-containing triple therapy : a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong", Helicobacter, 14, pp.505~511 (2009)
94. Molina-Infante J, "Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication", Aliment Pharmacol Ther, 31, pp.1077~1084 (2010)
95. Iacopini F, "One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication", Dig Liver Dis, 37, pp.571~576 (2005)
96. Li Y, "Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection : a meta analysis", Wien Klin Wochenschr, 122, pp.413~422 (2010)
97. Nam PT, "Antibiotic resistance of Helicobacter pylori with E-test in central region of Vietnam in two years 2012-2013", Vietnamese J Gastroenterol, 8, pp.2122~2132 (2013)
98. Toan ND, "Helicobacter pylori gene mutation associated with primary resistance to clarithromycin in duodenal ulcer patients", Vietnamese J Gastroenterol, 8, pp.1946~1951 (2013)
99. Trung NT, "Establishing a molecular biology procedure for detecting Helicobacter pylori", Vietnamese J Gastroenterol, 8, pp.1990~1996 (2013)
100. Trung TT, "Primary study of clarithromycin and levofloxacin resistant mutation of H. pylori by gene sequencing", Vietnamese J Gastroenterol, 9, pp.2367~2375 (2014)
101. Dung HD, "Characterization of point mutations in 23s rRNA gene in Clarithromycin resistant Helicobacter pylori", Vietnamese J Gastroenterol, 9, pp.2384~2389 (2014)
102. Doanh PN, "Clarithromycin resistance point mutation of H. pylori in Quang Ngai Province", Vietnamese J Gastroenterol, 9, pp.2620~2628 (2014)

관련 논문AI추천